Ceftolozane-Tazobactam Activity against Phylogenetically Diverse Clostridium difficile Strains

Ceftolozane-tazobactam (C/T) is approved for the treatment of complicated intra-abdominal and urinary tract infections and has varied activity against anaerobic bacteria. Here, we evaluate the activity of C/T against a phylogenetically diverse collection of Clostridium difficile isolates and report...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Gonzalez, Mark D., Wallace, Meghan A., Hink, Tiffany, Dubberke, Erik R., Burnham, Carey-Ann D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604413/
https://ncbi.nlm.nih.gov/pubmed/26282409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01670-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados